This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kusama, T. Articles by Nakamura, H. Search for Related Content PubMed PubMed Citation Articles by Kusama, T. Articles by Nakamura, H.

Inhibition of Epidermal Growth Factor-induced RhoA Translocation and Invasion of Human Pancreatic Cancer Cells by 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Inhibitors¹

Departments of Tumor Biochemistry [T. K., M. M., H. A., H. N.] and Gastrointestinal Oncology [M. T.], Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka 537-8511, Japan; First Department of Surgery, Yamanashi Medical University, Yamanashi 409-3898, Japan [T. K., Y. M.]; and First Department of Pathology, Hyogo College of Medicine, Nishinomiya 663-8501, Japan [T. I., H. A.]

3-Hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors prevent the conversion of HMG-CoA to mevalonate and thereby inhibit the synthesis of other products derived from this metabolite. This includes a number of small prenylated GTPases involved in cell growth, motility, and invasion. We studied the effect of HMG-CoA reductase inhibitors (fluvastatin and lovastatin) on in vitro invasion of human pancreatic cancer PANC-1 cells. Epidermal growth factor (EGF) induced a dose-dependent increase of PANC-1 cell invasion in a modified Boyden chamber assay. Stimulation of cancer cells with EGF induced translocation of RhoA from the cytosol to the membrane fraction and actin stress fiber assembly. Furthermore, Clostridium botulinum C3 transferase, a specific inhibitor of Rho, inhibited the ability of EGF to promote invasion, indicating that EGF-induced cancer cell invasion is regulated by Rho signaling. Treatment of PANC-1 cells with fluvastatin markedly attenuated EGF-induced translocation of RhoA from the cytosol to the membrane fraction and actin stress fiber assembly, whereas it did not inhibit the tyrosine phosphorylation of EGF receptor and c-erbB-2. The induction of cancer cell invasion by EGF was inhibited by the addition of fluvastatin or lovastatin in a dose-dependent manner. The effects of fluvastatin or lovastatin on cell morphology and invasion were reversed by the addition of all-trans-geranylgeraniol but not by the addition of all-trans-farnesol. These results suggest that HMG-CoA reductase inhibitors affect RhoA activation by preventing geranylgeranylation, which results in inhibition of EGF-induced invasiveness of human pancreatic cancer cells.

This article has been cited by other articles:

				R. J. Hamilton, K. C. Goldberg, E. A. Platz, and S. J. Freedland The Influence of Statin Medications on Prostate-specific Antigen Levels J Natl Cancer Inst, November 5, 2008; 100(21): 1511 - 1518. [Abstract] [Full Text] [PDF]

				J. Woodard, A. Sassano, N. Hay, and L. C. Platanias Statin-Dependent Suppression of the Akt/Mammalian Target of Rapamycin Signaling Cascade and Programmed Cell Death 4 Up-Regulation in Renal Cell Carcinoma Clin. Cancer Res., July 15, 2008; 14(14): 4640 - 4649. [Abstract] [Full Text] [PDF]

				W. R. Farwell, R. E. Scranton, E. V. Lawler, R. A. Lew, M. T. Brophy, L. D. Fiore, and J. M. Gaziano The Association Between Statins and Cancer Incidence in a Veterans Population J Natl Cancer Inst, January 16, 2008; 100(2): 134 - 139. [Abstract] [Full Text] [PDF]

				S. Kotamraju, C. L. Willams, and B. Kalyanaraman Statin-Induced Breast Cancer Cell Death: Role of Inducible Nitric Oxide and Arginase-Dependent Pathways Cancer Res., August 1, 2007; 67(15): 7386 - 7394. [Abstract] [Full Text] [PDF]

				V. Khurana, H. R. Bejjanki, G. Caldito, and M. W. Owens Statins Reduce the Risk of Lung Cancer in Humans: A Large Case-Control Study of US Veterans Chest, May 1, 2007; 131(5): 1282 - 1288. [Abstract] [Full Text] [PDF]

				K. S. Ahn, G. Sethi, and B. B. Aggarwal Simvastatin Potentiates TNF-{alpha}-Induced Apoptosis through the Down-Regulation of NF-{kappa}B-Dependent Antiapoptotic Gene Products: Role of I{kappa}B{alpha} Kinase and TGF-beta-Activated Kinase-1 J. Immunol., February 15, 2007; 178(4): 2507 - 2516. [Abstract] [Full Text] [PDF]

				H. Liu, D. C. Radisky, C. M. Nelson, H. Zhang, J. E. Fata, R. A. Roth, and M. J. Bissell Mechanism of Akt1 inhibition of breast cancer cell invasion reveals a protumorigenic role for TSC2. PNAS, March 14, 2006; 103(11): 4134 - 4139. [Abstract] [Full Text] [PDF]

				K. Hindler, C. S. Cleeland, E. Rivera, and C. D. Collard The Role of Statins in Cancer Therapy. Oncologist, January 1, 2006; 11(3): 306 - 315. [Abstract] [Full Text] [PDF]

				C. Pioche-Durieu, C. Keryer, S. Souquere, J. Bosq, W. Faigle, D. Loew, M. Hirashima, N. Nishi, J. Middeldorp, and P. Busson In Nasopharyngeal Carcinoma Cells, Epstein-Barr Virus LMP1 Interacts with Galectin 9 in Membrane Raft Elements Resistant to Simvastatin J. Virol., November 1, 2005; 79(21): 13326 - 13337. [Abstract] [Full Text] [PDF]

				M. Mukai, T. Kusama, Y. Hamanaka, T. Koga, H. Endo, M. Tatsuta, and M. Inoue Cross Talk between Apoptosis and Invasion Signaling in Cancer Cells through Caspase-3 Activation Cancer Res., October 15, 2005; 65(20): 9121 - 9125. [Abstract] [Full Text] [PDF]

				W-B Zhong, Y-C Liang, C-Y Wang, T-C Chang, and W-S Lee Lovastatin suppresses invasiveness of anaplastic thyroid cancer cells by inhibiting Rho geranylgeranylation and RhoA/ROCK signaling Endocr. Relat. Cancer, September 1, 2005; 12(3): 615 - 629. [Abstract] [Full Text] [PDF]

				A. Horiguchi, M. Sumitomo, J. Asakuma, T. Asano, T. Asano, and M. Hayakawa 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Inhibitor, Fluvastatin, as a Novel Agent for Prophylaxis of Renal Cancer Metastasis Clin. Cancer Res., December 15, 2004; 10(24): 8648 - 8655. [Abstract] [Full Text] [PDF]

				Y. Goldshmit, C. E. Walters, H. J. Scott, C. J. Greenhalgh, and A. M. Turnley SOCS2 Induces Neurite Outgrowth by Regulation of Epidermal Growth Factor Receptor Activation J. Biol. Chem., April 16, 2004; 279(16): 16349 - 16355. [Abstract] [Full Text] [PDF]

				O. Rey, J. Yuan, S. H. Young, and E. Rozengurt Protein Kinase C{nu}/Protein Kinase D3 Nuclear Localization, Catalytic Activation, and Intracellular Redistribution in Response to G Protein-coupled Receptor Agonists J. Biol. Chem., June 20, 2003; 278(26): 23773 - 23785. [Abstract] [Full Text] [PDF]

				S. Guha, J. A. Lunn, C. Santiskulvong, and E. Rozengurt Neurotensin Stimulates Protein Kinase C-dependent Mitogenic Signaling in Human Pancreatic Carcinoma Cell Line PANC-1 Cancer Res., May 15, 2003; 63(10): 2379 - 2387. [Abstract] [Full Text] [PDF]

				N. M. Rubenstein, Y. Guan, P. L. Woo, and G. L. Firestone Glucocorticoid Down-regulation of RhoA Is Required for the Steroid-induced Organization of the Junctional Complex and Tight Junction Formation in Rat Mammary Epithelial Tumor Cells J. Biol. Chem., March 14, 2003; 278(12): 10353 - 10360. [Abstract] [Full Text] [PDF]

				K. K. W. Chan, A. M. Oza, and L. L. Siu The Statins as Anticancer Agents Clin. Cancer Res., January 1, 2003; 9(1): 10 - 19. [Abstract] [Full Text] [PDF]

				K. Sawada, K.-i. Morishige, M. Tahara, R. Kawagishi, Y. Ikebuchi, K. Tasaka, and Y. Murata Alendronate Inhibits Lysophosphatidic Acid-induced Migration of Human Ovarian Cancer Cells by Attenuating the Activation of Rho Cancer Res., November 1, 2002; 62(21): 6015 - 6020. [Abstract] [Full Text] [PDF]

				S. Guha, O. Rey, and E. Rozengurt Neurotensin Induces Protein Kinase C-dependent Protein Kinase D Activation and DNA Synthesis in Human Pancreatic Carcinoma Cell Line PANC-1 Cancer Res., March 1, 2002; 62(6): 1632 - 1640. [Abstract] [Full Text] [PDF]

				K. L. O'Connor and A. M. Mercurio Protein Kinase A Regulates Rac and Is Required for the Growth Factor-stimulated Migration of Carcinoma Cells J. Biol. Chem., December 14, 2001; 276(51): 47895 - 47900. [Abstract] [Full Text] [PDF]